Articles

The Permissible Ingredients Determination has been updated.

Acalabrutinib receives approval through the second international collaborative review initiative between the TGA, FDA and Health Canada

The TGA has joined the ICMRA and the WHO in a coordinated global approach to fighting antimicrobial resistance

Consumer Healthcare Products Australia to handle all medicine advertising pre-approval applications

General information for consumers on prescription opioids

From animals intestines to intrauterine devices, contraception has a fascinating history.

The history of vaccination is a long and fascinating one.

The Complementary Healthcare Council of Australia is no longer accepting advertising pre-approval applications

The Therapeutic Goods (Permissible Indications) Determination has been updated

The Therapeutic Goods Administration is aware that a member of the public has purported to be a Commonwealth public official during a recent incident in Melbourne

Be informed and aware, but don’t be afraid.

A warning to consumers about undergoing procedures using unapproved medical devices

Learn about the evidence for medicinal cannabis, and how a medical doctor can organise medicinal cannabis access on behalf of appropriate patients.

Changes are coming in November to the advertising pre-approval arrangements for some complementary medicines advertisements

What does Neo from the Matrix need to know before choosing a pill to take?

Therapeutic Goods (Declared Goods) Order 2019 consolidates and replaces several instruments

Japan has recently been added to the list of Foreign Countries and Jurisdictions determined to be comparable overseas regulators

Considering microneedling? Make sure you do your research first

Contamination has been discovered in some ranitidine products, but the immediate health risk is low.

Consumer Medicine Information gives you the information you need to manage your health

The TGA has released the findings of its review into breast implants and breast tissue expanders

Fun facts about pirate medicine for Talk Like A Pirate Day

International Collaborative Review Initiative gives provisional approval of lenvatinib in combination with pembrolizumab

Commonly asked questions about stem cells and regulation

Infringement notice issued for the alleged advertising of Schedule 4 substances